Headline News Archive
Click on title to read the full article.
New treatment shows promise in the fight against breast cancer
March 31, 2020
Scientists have come up with a promising treatment to delay the growth and spread of breast cancer tumors.
Denosumab Superior for Bone Metastases, But of 'Debatable Value'
March 30, 2020
By Zosia Chustecka
More clinical trial data — from 2 pivotal studies — have been published showing that the novel bone-modifying drug denosumab (Xgeva, Amgen) is superior to zoledronic acid in preventing skeletal-related events (SREs) in cancer patients with bone metastases.
Interventional Radiologists Provide Hope in Delaying Growth, Spread of Breast Cancer
March 29, 2020
By The Society of Interventional Radiology
The growth and spread of breast cancer tumors may be delayed with a promising treatment that combines two innovative strategies: blocking the enzyme needed to "energize" cancer cells and infusing a potent drug directly into the tumor, with minimum exposure to healthy tissues, indicate researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.
New Targets Found for Aggressive Breast Cancer
March 25, 2020
By /source Harvard Medical School
With currently available early-detection methods for breast cancer, many people can be treated successfully. But for the 20 percent of patients with so-called triple-negative breast cancer, the outcome is bleak. Now, however, researchers from Harvard Medical School and Baylor College of Medicine have identified a critical molecular component to the disease.
Can Biopsies of Liver Metastases Improve Treatment Choice?
March 23, 2020
By Anna Azvolinsky
Analyses of the levels of estrogen receptor (ER), progesterone(Drug information on progesterone) receptor (PgR), and human epidermal growth factor receptor 2 (HER2) are standard practice following an initial breast cancer diagnosis. This characterization is important to subtype the cancer and determines the choice of therapy.
Seven-Day On-Off Capecitabine Cycle Treats Breast Cancer
March 23, 2020
Treatment of metastatic breast cancer with capecitabine administered for seven days followed by seven days of rest in combination with bevacizumab has modest efficacy and minimal toxicity, as indicated by mathematical predictions, according to a study published online March 8 in Cancer.
Lifting the Fog
March 22, 2020
By Elaine Schattner
New research helps clarify chemobrain.
Revised Guidelines on Metastatic Breast Cancer Bone Metastases
March 22, 2020
By Anne Azvolinsky, PhD
The American Society of Clinical Oncology (ASCO) updated its recommendation last month on the role of bone-modifying agents in the prevention of skeletal-related events (SREs) for metastatic breast cancer patients with bone metastases
Primary tumour excision in metastatic breast cancer impacts on survival
March 21, 2020
By Janet Fricker
Operating on patients with metastatic breast cancer to reduce their total tumour burden improves overall survival, reports a Pakistani abstract at the International Breast Cancer Conference (St Gallen, Switzerland, 16-19 March).
Hurdles on the Faster Track
March 21, 2020
By Mike King
Patients & the FDA struggle over how to define success in the battle against metastatic disease.
Headline News Archive
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- October 2007
- September 2007